* Cardinal Health Inc reported quarterly adjusted earnings of $2.08 per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $1.74. The mean expectation of fifteen analysts for the quarter was for earnings of $1.95 per share. Wall Street expected results to range from $1.89 to $2.02 per share.
* Revenue rose 8.8% to $54.91 billion from a year ago; analysts expected $56.05 billion.
* Cardinal Health Inc's reported EPS for the quarter was $1.05.
* The company reported quarterly net income of $258 million.
* Cardinal Health Inc shares had fallen by 8.7% this quarter and gained 1.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 1.4% in the last three months.
* In the last 30 days, six analysts negatively revised earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 10 "hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the pharmaceuticals peer group is "hold."
Wall Street's median 12-month price target for Cardinal Health Inc is $115.50 This summary was machine generated from LSEG data May 2 at 01:53 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 1.95 2.08 Beat
Dec. 31 2023 1.60 1.82 Beat
Sep. 30 2023 1.40 1.73 Beat
1.49
Comments